Cyclin-Dependent Kinase 9 (CDK9) Inhibitor Pipeline Research Report 2024: Drugs in Development, Therapeutics Scenario and Growth Prospects
April 15, 2024 11:28 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's...
CDK9 inhibitor Drug Pipeline Research Report 2024
April 12, 2024 07:29 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "CDK9 inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent Kinase 9 (CDK9)...
Janus Kinase (JAK) Inhibitor Market Forecast 2024-2034: Analyzes Trends Likely to Shape Future Opportunities
March 14, 2024 04:30 ET
|
Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...
Global Orphan Drugs Research Analysis Report 2023: Growing Approvals of Innovative Orphan Drugs Propel Market Expansion, Biologics Lead the Way - Forecasts to 2034
January 31, 2024 11:22 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drugs Market Analysis & Forecast 2024-2034: Market By Drug Type; By Therapy; By Distribution Channel; and By Region" report has been...
SM04690 for Osteoarthritis: Emerging Drug Insight and Market Forecasts to 2032 - Focus on 6 Major Markets
January 24, 2024 08:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SM04690 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "SM04690 Emerging Drug...
K-321 (Ripasudil) for Fuchs Endothelial Corneal Dystrophy (FECD): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:12 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "K-321 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Emerging Fanconi Anemia Treatment RP-L102 Drug Insight and Market Forecasts to 2032
January 24, 2024 08:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "RP-L102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry professionals and...
JAKAFI (Ruxolitinib) Emerging Drug Insights and Market Forecasts, 2019-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
January 24, 2024 07:57 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "JAKAFI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
Healthcare Industry Report: DB102 Emerging Drug Insights and Market Forecast for DLBCL through 2032
January 24, 2024 07:47 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DB102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. A newly compiled research report...
Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight Report 2024: Combining CDC7 Kinase Inhibitors with Existing Cancer Therapies for Enhanced Efficacy
January 11, 2024 05:28 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...